Adaptyv Biosystems Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Adaptyv Biosystems Inc. - overview
Established
2021
Location
Lausanne, -, Switzerland
Primary Industry
Biotechnology
About
Based in Switzerland, Adaptyv Biosystems develops a protein engineering platform using cell-free synthetic biology and nanofluidics. Based in Switzerland and founded in 2021, Adaptyv Biosystems Sàrl operates as a Biopole-based company. Daniel Nakhaee-Zadeh Gutierrez, Amir Shahein, Moustafa Houmani, and Julian Englert are the co-founders of the company. In August 2026, Adaptyv Biosystems Inc.
raised USD 40 million series A funding led by new investor Highland Europe, with participation from returning investors Ace Ventures, byFounders and Y Combinator. The company develops a protein engineering platform that uses automated nanofluidic platforms and cell-free systems. Rather than depending on genetically modified live cells to manufacture the desired protein, cell-free systems rely solely on biochemical components to convert a DNA sequence into a protein. Cell-free systems can be downsized and automated by avoiding the handling of living cells, making them a fit for high-throughput procedures that screen thousands of protein variations at once.
Current Investors
Y Combinator, Acequia Capital, Rheingau Founders, Founders, Venture Kick, Highland Europe, byFounders, ACE Ventures, Founderful, FAST by GETTYLAB, Hawktail, Axial VC, S2S Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.adaptyvbio.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Adaptyv Biosystems Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | Adaptyv Biosystems Inc. | - | ||||||||
| Seed | Completed | Adaptyv Biosystems Inc. | - | ||||||||
| Unspecified Round | Completed | Adaptyv Biosystems Inc. | - |
Displaying 1 - 3 of 3
Adaptyv Biosystems Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.